To determine whether the change in arterial stiffness result from improved glycemic control per se in active treatment group or from other factors such as exposure to metformin, change in insulin resistance or adiponectin levels, general linear model of change from baseline AI (Δ AI) was carried out. This evidence concerns the gene ADIPOQ and Insulin resistance.